FOXP3 and neoplasm: In another example, treatment with AMD3100, a selective CXCR4 antagonist, resulted in increased tumor cell apoptosis and necrosis, and selective reduction of foxp3+ regulatory T cells and inducing an immunosuppressive microenvironment [36].